---
figid: PMC12022909__oc5c00194_0001
figtitle: AhR-based drug discovery
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12022909
filename: oc5c00194_0001.jpg
figlink: /pmc/articles/PMC12022909/figure/F1/
number: F1
caption: 'AhR-based drug discovery. (a) Main signaling pathway of AhR after ligand
  activation. (b) Known AhR ligands. (c) This work: a unified platform for AhR-based
  drug discovery. (d) The role of indole-2-CHO in various MCRs. Representative reaction
  conditions: (i) Yb(OTf)3·H2O (20 mol %), CH3CN, rt, 72 h; (ii) MeOH, rt, 8 h; (iii)
  AgNO3 (10 mol %), MeOH, rt, 17 h; (iv) THF, reflux, 17 h; (v) l-proline (10 mol
  %), EtOH, 80 °C, 4 h. See Figure S1 for detailed reaction conditions'
papertitle: |-
  A Multicomponent
  Reaction-Based Platform Opens New
  Avenues in Aryl Hydrocarbon Receptor Modulation
reftext: Pau Nadal Rodríguez, et al. ACS Cent Sci. 2025 Apr 23;11(4).
year: '2025'
doi: 10.1021/acscentsci.5c00194
journal_title: ACS Central Science
journal_nlm_ta: ACS Cent Sci
publisher_name: American Chemical Society
keywords: ''
automl_pathway: 0.7562739
figid_alias: PMC12022909__F1
figtype: Figure
redirect_from: /figures/PMC12022909__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12022909__oc5c00194_0001.html
  '@type': Dataset
  description: 'AhR-based drug discovery. (a) Main signaling pathway of AhR after
    ligand activation. (b) Known AhR ligands. (c) This work: a unified platform for
    AhR-based drug discovery. (d) The role of indole-2-CHO in various MCRs. Representative
    reaction conditions: (i) Yb(OTf)3·H2O (20 mol %), CH3CN, rt, 72 h; (ii) MeOH,
    rt, 8 h; (iii) AgNO3 (10 mol %), MeOH, rt, 17 h; (iv) THF, reflux, 17 h; (v) l-proline
    (10 mol %), EtOH, 80 °C, 4 h. See Figure S1 for detailed reaction conditions'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AHR
  - ARNT
  - MIA3
  - C1QA
  - C1QB
  - C1QC
  - C1R
  - C1S
  - NR3C2
  - CAT
  - CRAT
  - GLYAT
  - PPIG
  - CYP17A1
  - CYP19A1
  - CYP20A1
  - CYP21A2
  - CYP24A1
  - CYP39A1
  - TBXAS1
  - CYP46A1
  - CYP51A1
  - CYP1A1
  - CYP1A2
  - CYP1B1
  - CYP11A1
  - CYP11B1
  - CYP11B2
  - CYP2A13
  - CYP2A6
  - CYP2A7
  - CYP2B6
  - CYP2C18
  - CYP2C19
  - CYP2C8
  - CYP2C9
  - CYP2D6
  - CYP2D7
  - CYP2E1
  - CYP2F1
  - CYP2J2
  - CYP2R1
  - CYP2S1
  - CYP2U1
  - CYP2W1
  - CYP26A1
  - CYP26B1
  - CYP26C1
  - CYP27A1
  - CYP27B1
  - CYP27C1
  - CYP3A4
  - CYP3A43
  - CYP3A5
  - CYP3A7
  - CYP4A11
  - CYP4A22
  - CYP4B1
  - CYP4F11
  - CYP4F12
  - CYP4F2
  - CYP4F22
  - CYP4F3
  - CYP4F8
  - CYP4V2
  - CYP4X1
  - CYP4Z1
  - CYP7A1
  - CYP7B1
  - CYP8B1
  - PTGIS
  - F3
  - Nucleus
  - TCDD
  - -NC
  - -NH2
  - psoriasis
  - Cancer
---
